the Berlin patient should have more of the current results of the German top-level research. To knowledge and medicinal products, it should of still ongoing studies to better use, especially in tumor treatment. At the same time, all of the individual application in question methods and medicines could be stored on an electronic patient file that can be read by any attending physician.
To this recommendation, the Senate’s chief, Michael Müller (SPD) convened a future Commission made up of “health city Berlin 2030”. The head of the SPD Federal politician Karl Lauterbach, presented on Monday in the Red town hall a report of results of the eleven-member Board.
collaboration between Charité and Vivantes should be better
The capital, have the potential for international medical research metropolis, said Lauterbach, so far, but much of the course side by side. They wanted to expand in Berlin in 2030 for the “Top international address in the medical research and care” – whether it is necessary to improve the cooperation of Charité and Vivantes, the digitization of advancing and industry-specific administrative staff in a private Academy to train.
The state-owned corporations Charité and Vivantes have 9600 the 22,000 hospital beds in the city and provide 42 percent of the clinic patients. As a result, the country is able to control the orientation of the houses, in addition, the potential for research studies in which they exist in this size anywhere in Germany.
daily mirror people
for Free order
The University hospital should focus on the high-performance medicine, Vivantes on the mass supply, said Lauterbach. At the same time, but the Vivantes patients would benefit from ongoing research studies of the Charité.
The tasks would be done under the umbrella of a state-owned company is best. The roof company should be, if possible, even the Berlin Institute for health research, that is already close to the Charité is connected, and the new, under construction, University heart centre.
Because so much had to be coordinated, to the Senate of a special representative. As reported: According to daily mirror information Müller and Lauterbach for Ex-health Secretary of state, Boris Velter (SPD). The Senate confirmed the.
Charité, is still living, of your reputation
SPD-health expert Lauterbach is for clear words to be known, which is why Muller asked. The value of is approximately, said Lauterbach, that the Senate is able to control the Charité and Vivantes, almost half of the hospital sector of Berlin – both clinics belong to the Land the have, however, invested too long: “90 percent of the devices in the Charité are written off.”
This means that you can do with them, it is good medicine, but in the international top-level research can hardly keep up. “Because you always need the latest top machines.” Müller said that he had requested further investment for the Charité.
Lauterbach: “The Charité wins a lot of third-party funds, but the share of the funds, which were previously advertised, is low.” This means that the University hospital compete hardly in order to research money, but live by your reputation – but don’t go on forever. “Berlin’s healthcare facilities need a clear design concept – yet much of it is there for historical reasons.” Means that sites do not receive, because you get used to it – because there are the ideal places.
More about
Berlin’s Charité University clinic 2500 nurses in private school
Hannes Heine
what is the response of the clinics, Large want? The Commission was also Heyo Kroemer in September, the post of CEO of the Charité. There is hardly any resistance. And the Vivantes Board informed: The Commission support the Vivantes-orientation as a “cross-sector health care providers” and “ideal partner” for research. The proposals will soon be discussed in the house of representatives, in addition, the members of the Supervisory Board of Vivantes and Charité want to days together.
